سعر روفيرون ا 3وحدة عالمية/0.5مل 2022

Interferon alfa-2a 3 million IU/0.5 ml solution for subcutaneous injection in a prefilled syringe, Roche.

• Hairy cell leukaemia.ANSM (Agence nationale de sécurité du médicament)
• Philadelphia-positive chronic myeloid leukaemia in chronic phase.ANSM (Agence nationale de sécurité du médicament)
• Cutaneous T-cell lymphoma.ANSM (Agence nationale de sécurité du médicament)

• Flu-like syndrome (fatigue, fever, chills, loss of appetite, myalgia, headache, arthralgia, sweating) in most patients; in cancer patients anorexia (about two thirds) and nausea (about half); cardiovascular effects (transient hypotension, hypertension, oedema, arrhythmia, chest pain) in about one fifth of cancer patients.International label, same product · ANSM (Agence nationale de sécurité du médicament)

• Hypersensitivity to recombinant interferon alfa-2a or any excipient.International label, same product · ANSM (Agence nationale de sécurité du médicament)
• Severe pre-existing cardiac disease or history of cardiac disease.International label, same product · ANSM (Agence nationale de sécurité du médicament)
• Severe renal, hepatic or bone-marrow insufficiency.International label, same product · ANSM (Agence nationale de sécurité du médicament)

• Record the product name for traceability of biologics; administer under a qualified physician with diagnostic and therapeutic facilities available; stop treatment if a hypersensitivity reaction occurs.International label, same product · ANSM (Agence nationale de sécurité du médicament)

• TheophyllineRoferon-A reduces theophylline clearance.ANSM (Agence nationale de sécurité du médicament)
• Centrally acting medicinesPossible interactions due to CNS activity of interferon.ANSM (Agence nationale de sécurité du médicament)
• Drugs with neurological, haematological or cardiac toxicityToxic effects may be increased by interferons.ANSM (Agence nationale de sécurité du médicament)

• Men and women should use effective contraception; insufficient data in pregnancy; abortifacient effect in rhesus monkeys at high doses; use in pregnancy only if benefit justifies fetal risk.International label, same product · ANSM (Agence nationale de sécurité du médicament)
• No data on passage into breast milk; decide between stopping breastfeeding or stopping treatment based on the benefit to the mother.International label, same product · ANSM (Agence nationale de sécurité du médicament)